Double-Chin Drug Meets Two Late-Stage Goals

Source: BusinessWeek

Sep 19, 2013

Kythera said its ATX-101 injection reached its main and secondary goals in the trials. The drug reportedly worked better than placebo a reducing fat in the submental area of the neck, which can create the appearance of a double chin. ATX-101 is intended to destroy fat cells while leaving other tissue largely unaffected. Read the full story.

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.


No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments